We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$460M
AUM Growth
+$50.5M
Cap. Flow
+$24.1M
Cap. Flow %
5.24%
Top 10 Hldgs %
32.28%
Holding
73
New
3
Increased
49
Reduced
15
Closed

Sector Composition

1 Industrials 20.38%
2 Consumer Discretionary 19.34%
3 Technology 18.19%
4 Consumer Staples 11.54%
5 Healthcare 11.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
26
Nike
NKE
$65.5B
$8.9M 1.94%
142,347
+4,398
+3% +$253K
AON icon
27
Aon
AON
$78.7B
$8.86M 1.93%
66,089
+9,118
+16% +$1.3M
GILD icon
28
Gilead Sciences
GILD
$172B
$8.57M 1.86%
119,676
+7,663
+7% +$582K
PII icon
29
Polaris
PII
$4.19B
$8.47M 1.84%
68,344
+1,977
+3% +$235K
CBRL icon
30
Cracker Barrel
CBRL
$1.17B
$8.2M 1.78%
51,626
+2,401
+5% +$377K
DLTR icon
31
Dollar Tree
DLTR
$25.1B
$8.09M 1.76%
75,429
+2,763
+4% +$270K
COL
32
DELISTED
Rockwell Collins
COL
$7.12M 1.55%
52,504
+3,675
+8% +$493K
NVO
33
Novo Nordisk
NVO
$224B
$6.99M 1.52%
260,344
+34,172
+15% +$869K
CNI icon
34
Canadian National Railway
CNI
$78.3B
$6.87M 1.49%
83,221
+6,013
+8% +$484K
ABBV icon
35
AbbVie
ABBV
$457B
$6.8M 1.48%
70,277
+4,643
+7% +$438K
SYK icon
36
Stryker
SYK
$124B
$6.5M 1.41%
41,987
+5,997
+17% +$915K
SLGN icon
37
Silgan Holdings
SLGN
$5.04B
$6.03M 1.31%
205,292
+7,950
+4% +$230K
ORLY icon
38
O'Reilly Automotive
ORLY
$71.9B
$5.64M 1.23%
351,645
+11,025
+3% +$164K
K
39
DELISTED
Kellanova
K
$4.08M 0.89%
63,979
+4,257
+7% +$256K
RTN
40
DELISTED
Raytheon Company
RTN
$3.62M 0.79%
19,262
+887
+5% +$165K
HSIC icon
41
Henry Schein
HSIC
$10B
$3.22M 0.7%
58,757
-7,602
-11% -$441K
LH icon
42
Labcorp
LH
$23.4B
$3.2M 0.7%
23,338
+4,106
+21% +$543K
LEA icon
43
Lear
LEA
$7.16B
$3.1M 0.67%
17,562
+2,245
+15% +$394K
EXPD icon
44
Expeditors International
EXPD
$23.8B
$2.75M 0.6%
42,572
+861
+2% +$52.8K
KMB icon
45
Kimberly-Clark
KMB
$36.4B
$2.7M 0.59%
22,392
FDS icon
46
Factset
FDS
$9.17B
$2.59M 0.56%
13,419
+1,666
+14% +$320K
ALK icon
47
Alaska Air
ALK
$5.13B
$2.43M 0.53%
33,065
-1,082
-3% -$76.9K
LLY icon
48
Eli Lilly
LLY
$1.05T
$2.38M 0.52%
28,219
+258
+0.9% +$22K
RHI icon
49
Robert Half
RHI
$4.21B
$2.25M 0.49%
40,616
+295
+0.7% +$15.7K
MTD icon
50
Mettler-Toledo International
MTD
$26.5B
$2.08M 0.45%
3,363
+931
+38% +$596K

Similar funds

JLB & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, JLB & Associates held 73 positions worth $460M, up 12% from $409M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

JLB & Associates deployed $24.1M of net new capital in Q4 2017, opening 3 new positions and adding to 49 existing holdings. Its largest new stake was Sherwin-Williams: 7,086 shares worth $968K.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Hanesbrands, an estimated $895K trimmed.

  • JLB & Associates's largest Q4 2017 buy was Sherwin-Williams: 7,086 shares worth $968K.
  • JLB & Associates added most to Apple in Q4 2017, an estimated $1.5M increase.
  • JLB & Associates's biggest Q4 2017 reduction was Hanesbrands, cutting an estimated $895K.
  • JLB & Associates's ten largest holdings make up 32% of its $460M portfolio in Q4 2017.
  • JLB & Associates opened 3 new positions and closed 0 in Q4 2017.
  • JLB & Associates's portfolio value rose 12% quarter-over-quarter to $460M.

Based on JLB & Associates's 13F filing for Q4 2017, filed 24 Jan 2018.